Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KRAS
Pharma
Verastem nixes KRAS G12C plans in non-small cell lung cancer
Newer G12C inhibitors are “establishing a new benchmark with higher response rates,” Verastem’s chief medical officer said in explaining the move.
Angus Liu
Jan 2, 2026 10:10am
Angus on Angus: A Fierce oncology discussion
Apr 25, 2025 9:41am
Astellas, AstraZeneca, Glenmark and more—Fierce Pharma Asia
Sep 6, 2024 9:00am
FDA blasts Bristol Myers over misleading Krazati efficacy claims
Aug 8, 2024 10:59am
BMS and Mirati's KRAS inhibitor Krazati moves beyond NSLC
Jun 24, 2024 8:53am
ASCO: BMS' confirmatory KRAS data leave FDA prospects unclear
Jun 1, 2024 8:00am
